Maxcyte Inc (MXCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 6,495 | 8,514 | 6,763 | 5,150 | 5,742 |
| Cost of Goods | 693 | 907 | 735 | 466 | 659 |
| Gross Profit | 5,802 | 7,607 | 6,028 | 4,684 | 5,083 |
| Operating Expenses | 12,868 | 10,905 | 9,605 | 7,995 | 8,730 |
| Operating Income | -6,373 | -2,391 | -2,842 | -2,845 | -2,988 |
| Interest Expense | 742 | 282 | 263 | 165 | 116 |
| Other Income | 10 | 22 | 7 | 5 | 43 |
| Pre-tax Income | -7,106 | -2,651 | -3,099 | -3,004 | -3,062 |
| Net Income Continuous | -7,106 | -2,651 | -3,099 | -3,004 | -3,062 |
| Net Income | $-7,106 | $-2,651 | $-3,099 | $-3,004 | $-3,062 |
| EPS Basic Total Ops | -0.09 | -0.03 | -0.04 | -0.05 | -0.05 |
| EPS Basic Continuous Ops | -0.09 | -0.03 | -0.04 | -0.05 | -0.05 |
| EPS Diluted Total Ops | -0.09 | -0.03 | -0.04 | -0.05 | -0.05 |
| EPS Diluted Continuous Ops | -0.09 | -0.03 | -0.04 | -0.05 | -0.05 |
| EBITDA(a) | $-6,050 | $-2,110 | $-2,556 | $-2,590 | $-2,766 |